Medix (UK) launches portable asthma therapy
This article was originally published in Clinica
Bespak Group company Medix (UK) has introduced an ultrasonic nebuliser designed to be small and quiet enough to be used anywhere. The Sonix 2000 system can be powered by any mains voltage, a rechargeable battery or car cigarette lighter socket.
You may also be interested in...
Lilly has launched a similar antibody product, but demand is expected to outpace supply for the foreseeable future.
Perrigo, Pfizer want the US FDA to postpone its March 1 deadline for conducting nitrosamine risk assessments. Generics exec cites“serious compliance challenges” in conducting these assessments due to difficulty in finding the right lab equipment necessary to quantify nitrosamine daily intake limits.
Deal snapshot: For $425m up front, the pharma obtains a Phase III recombination fusion protein that shows ability to improve hospitalized patients’ clinical status and reduce risk of death.